|
Apr 22
|
Sarepta Therapeutics to Announce First Quarter 2025 Financial Results
|
|
Apr 22
|
Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Long-Term Stock According to Analysts?
|
|
Apr 21
|
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
|
|
Apr 18
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
Apr 17
|
Sarepta Therapeutics (NASDAQ:SRPT investor one-year losses grow to 54% as the stock sheds US$166m this past week
|
|
Apr 16
|
SRPT Provides Pipeline Updates on Rare Muscular Disorder Therapies
|
|
Apr 16
|
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
|
|
Apr 15
|
Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs
|
|
Mar 31
|
Biotech Investors Rush for the Exits After FDA Official Resigns: Heard on the Street
|
|
Mar 31
|
Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'
|
|
Mar 31
|
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out
|
|
Mar 29
|
Is Sarepta Therapeutics (SRPT) the Best Mid Cap Biotech Stock to Buy?
|
|
Mar 28
|
Sarepta Therapeutics (SRPT) Down 30.3% Since Last Earnings Report: Can It Rebound?
|
|
Feb 20
|
Is Sarepta Therapeutics, Inc. (SRPT) The Best Fast Growth Stock To Buy Right Now?
|
|
Feb 17
|
Down -8.52% in 4 Weeks, Here's Why Sarepta Therapeutics (SRPT) Looks Ripe for a Turnaround
|
|
Feb 14
|
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility
|
|
Feb 12
|
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results
|
|
Feb 11
|
Q1 2025 Arrowhead Pharmaceuticals Inc Earnings Call
|
|
Jan 20
|
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
|
|
Dec 20
|
The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam
|